Dr. Sesay is the Chief Science Officer and Vice President of Bioconjugation Development at GBI. He has over 25 years of biotechnology experience in biologics process development and manufacturing, bioconjugation, and modification of biological and small molecules. Dr. Sesay has over 17 years of CDMO experience.